TrialBioscience reports2019

Serum thrombospondin-2 is a candidate diagnosis biomarker for early non-small-cell lung cancer.

Yi-Ming Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.